Zentalis Pharmaceuticals, Inc. (ZNTL)
3.775
+0.06
(+1.75%)
USD |
NASDAQ |
Sep 02, 16:00
3.775
0.00 (0.00%)
After-Hours: 19:41
Zentalis Pharmaceuticals Net Income (TTM) : -139.54M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -139.54M |
| March 31, 2026 | -124.13M |
| December 31, 2025 | -137.06M |
| September 30, 2025 | -149.32M |
| June 30, 2025 | -162.78M |
| March 31, 2025 | -224.19M |
| December 31, 2024 | -165.87M |
| September 30, 2024 | -179.33M |
| June 30, 2024 | -194.72M |
| March 31, 2024 | -219.00M |
| December 31, 2023 | -292.30M |
| September 30, 2023 | -286.35M |
| June 30, 2023 | -285.31M |
| March 31, 2023 | -241.14M |
| Date | Value |
|---|---|
| December 31, 2022 | -237.11M |
| September 30, 2022 | -232.22M |
| June 30, 2022 | -188.22M |
| March 31, 2022 | -174.89M |
| December 31, 2021 | -166.09M |
| September 30, 2021 | -156.35M |
| June 30, 2021 | -180.53M |
| March 31, 2021 | -152.76M |
| December 31, 2020 | -118.55M |
| September 30, 2020 | -92.74M |
| June 30, 2020 | -70.64M |
| March 31, 2020 | -53.95M |
| December 31, 2019 | -46.38M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ARS Pharmaceuticals, Inc. | -215.43M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |